Relationship between peroxisome proliferator-activated receptor γ and gestational diabetes mellitus

LIU Kezhuo; WANG Huiyan

doi:10.7619/jcmp.201919034

Journal of Clinical Medicine in Practice > 2019 > 23(19): 125-128. > DOI: 10.7619/jcmp.201919034

LIU Kezhuo, WANG Huiyan. Relationship between peroxisome proliferator-activated receptor γ and gestational diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2019, 23(19): 125-128. DOI: 10.7619/jcmp.201919034

Citation:

PDF (644 KB)

Relationship between peroxisome proliferator-activated receptor γ and gestational diabetes mellitus

More Information

Received Date: August 05, 2019
Accepted Date: September 11, 2019
Available Online: February 28, 2021
Published Date: October 14, 2019

Graphical Abstract

Abstract

FullText(HTML)

References (37)

References

[1]	李佳, 陈必良.胰岛素抵抗对妊娠期糖尿病影响的研究进展[J].中国妇幼健康研究, 2009, 20(6): 718-720. doi: 10.3969/j.issn.1673-5293.2009.06.043
[2]	胡玲, 王程琳, 郑文霞, 等.妊娠糖尿病患者脂肪因子炎症因子与胰岛素抵抗的关系[J].中国药物与临床, 2015, 15(6): 825-827. https://www.cnki.com.cn/Article/CJFDTOTAL-YWLC201506039.htm
[3]	叶爱玲, 颜勤明, 柴泽音, 等.妊娠期糖尿病视黄醇结合蛋白4与炎症因子、胰岛素抵抗相关分析[J].中国医师杂志, 2011(4): 480-483. doi: 10.3760/cma.j.issn.1008-1372.2011.04.015
[4]	Mørkrid K, Jenum A K, Sletner L, et al. Failure to increase insulin secretory capacity during pregnancy-induced insulin resistance is associated with ethnicity and gestational diabetes[J]. Eur J Endocrinol, 2012, 167(4): 579-588. doi: 10.1530/EJE-12-0452
[5]	Galic S, Oakhill J S, Steinberg G R. Adipose tissue as an endocrine organ[J]. Mol Cell Endocrinol, 2010, 316(2): 129-139. doi: 10.1016/j.mce.2009.08.018
[6]	杨谷良, 潘敏雄, 向福, 等. PPARγ调控脂肪细胞增殖和分化机理研究进展[J].食品科学, 2017, 38(3): 254-260. https://www.cnki.com.cn/Article/CJFDTOTAL-SPKX201703047.htm
[7]	Takada I, Makishima M. PPARγ ligands and their therapeutic applications: a patent review (2008-2014)[J]. Expert Opin Ther Pat, 2015, 25(2): 175-191. doi: 10.1517/13543776.2014.985206
[8]	Glass C K, Ogawa S. Combinatorial roles of nuclear receptors in inflammation and immunity[J]. Nat Rev Immunol, 2006, 6(1): 44-55. doi: 10.1038/nri1748
[9]	Taxvig C, Dreisig K, Boberg J, et al. Differential effects of environmental chemicals and food contaminants on adipogenesis, biomarker release and PPARγ activation[J]. Mol Cell Endocrinol, 2012, 361(1/2): 106-115.
[10]	Tenenbaum A, Fisman E Z. Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention[J]. Cardiovasc Diabetol, 2012, 11: 140. doi: 10.1186/1475-2840-11-140
[11]	Gross B, Staels B. PPAR agonists: multimodal drugs for the treatment of type-2 diabetes[J]. Best Pract Res Clin Endocrinol Metab, 2007, 21(4): 687-710. doi: 10.1016/j.beem.2007.09.004
[12]	Yadav A, Kataria M A, Saini V, et al. Role of leptin and adiponectin in insulin resistance[J]. Clin Chim Acta, 2013, 417: 80-84. doi: 10.1016/j.cca.2012.12.007
[13]	Pickup J C. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes[J]. Diabetes Care, 2004, 27(3): 813-823. doi: 10.2337/diacare.27.3.813
[14]	Black M H, Wu J, Takayanagi M, et al. Variation in PPARG is associated with longitudinal change in insulin resistance in Mexican Americans at risk for type 2 diabetes[J]. J Clin Endocrinol Metab, 2015, 100(3): 1187-1195. doi: 10.1210/jc.2014-3246
[15]	李吉隆, 周杰, 王宝利. microRNA-200c对3T3-L1前体脂肪细胞向脂肪细胞分化的调控作用[J].国际内分泌代谢杂志, 2017, 3(37): 2-2.
[16]	谢军, 韩造木. MiRNA-27a通过PPARγ介导3T3-L1细胞胰岛素抵抗[J].华南国防医学杂志, 2017, 31(5): 293-296. https://www.cnki.com.cn/Article/CJFDTOTAL-HNGY201705003.htm
[17]	谢军, 蔡克银. MiRNA-27a对3T3-L1细胞胰岛素抵抗的作用及机制[J].华南国防医学杂志, 2014, 28(2): 97-99, 112. https://www.cnki.com.cn/Article/CJFDTOTAL-HNGY201402003.htm
[18]	Capobianco E, White V, Higa R, et al. Effects of natural ligands of PPARgamma on lipid metabolism in placental tissues from healthy and diabetic rats[J]. Mol Hum Reprod, 2008, 14(8): 491-499. doi: 10.1093/molehr/gan039
[19]	潘小佳, 高宇, 朱智鹏. PPARγ在妊娠期糖尿病脂肪及胎盘组织的表达及临床意义[J].中国医学工程, 2015, 23(7): 165, 167. https://www.cnki.com.cn/Article/CJFDTOTAL-YCGC201507121.htm
[20]	李珍, 赖光锐, 宋薇薇. PPARγ在妊娠期糖尿病脂肪及胎盘组织的表达研究[J].国际遗传学杂志, 2014, 37(6): 278-303. doi: 10.3760/cma.j.issn.1673-4386.2014.06.002
[21]	Márkus B, Vörös K, Supák D, et al. Association of PPAR alpha intron 7 G/C, PPAR gamma 2 Pro12Ala, and C161T polymorphisms with serum fetuin-A concentrations[J]. PPAR Res, 2017, 2017: 7636019. http://europepmc.org/abstract/MED/28781590
[22]	Tok E C, Ertunc D, Bilgin O, et al. PPAR-gamma2 Pro12Ala polymorphism is associated with weight gain in women with gestational diabetes mellitus[J]. Eur J Obstet Gynecol Reprod Biol, 2006, 129(1): 25-30. doi: 10.1016/j.ejogrb.2006.03.016
[23]	Dong C P, He L, Li J N, et al. Association of the Pro12Ala and C1431T polymorphism of the PPAR gamma2 gene and their haplotypes with obesity and type 2 diabetes[J]. Chin J Med Genet, 2008, 25(4): 447-451. http://www.ncbi.nlm.nih.gov/pubmed/18683148/
[24]	Wang L H, Xu W T, Wang X. Peroxisome proliferator-activated receptor Pro12Ala polymorphism and the risks of gestational diabetes mellitus: An updated meta-analysis of 12 studies[J]. Medicine (Baltimore), 2016, 95(44): e5090. doi: 10.1097/MD.0000000000005090
[25]	张展, 蒋陈东, 冯杨, 等.过氧化物酶体增殖物激活受体γ2基因Pro12Ala多态性与妊娠期糖尿病的关系Meta分析[J].中华围产医学杂志, 2016, 19(4): 308-314. doi: 10.3760/cma.j.issn.1007-9408.2016.04.015
[26]	郭乌兰, 唐勇, 韩学尧, 等.中国汉族人群过氧化物酶体增殖物激活受体γ基因Pro12Ala多态性与2型糖尿病相关性的Meta分析[J].中国医学科学院学报, 2011, 33(6): 593-599. doi: 10.3881/j.issn.1000-503X.2011.06.002
[27]	程琰, 马瑶, 彭婷, 等.孕妇及其子代PPAR γ2基因型差异与妊娠期糖尿病发病的关系[J].中华妇产科杂志, 2010, 45(3): 170-173. https://cdmd.cnki.com.cn/Article/CDMD-10114-1020751107.htm
[28]	刘文惠, 杨晓红, 张元珍. PPAR-γ基因多态性与妊娠期糖尿病相关性的初步探讨[J].武汉大学学报:医学版, 2014, 35(1): 69-73 https://www.cnki.com.cn/Article/CJFDTOTAL-HBYK201401015.htm
[29]	Wang H Y, Jiang H Y, Yang L P, et al. Impacts of dietary fat changes on pregnant women with gestational diabetes mellitus: a randomized controlled study[J]. Asia Pac J Clin Nutr, 2015, 24(1): 58-64. http://europepmc.org/abstract/med/25740743
[30]	Ryckman K K, Spracklen C N, Smith C J, et al. Maternal lipid levels during pregnancy and gestational diabetes: a systematic review and meta-analysis[J]. BJOG, 2015, 122(5): 643-651. doi: 10.1111/1471-0528.13261
[31]	Leng J H, Shao P, Zhang C P, et al. Prevalence of gestational diabetes mellitus and its risk factors in Chinese pregnant women: a prospective population-based study in Tianjin, China[J]. PLoS One, 2015, 10(3): e0121029. http://www.ncbi.nlm.nih.gov/pubmed/25799433
[32]	Chon S J, Kim S Y, Cho N R, et al. Association of variants in PPARγ2, IGF2BP2, and KCNQ1 with a susceptibility to gestational diabetes mellitus in a Korean population[J]. Yonsei Med J, 2013, 54(2): 352-357. doi: 10.3349/ymj.2013.54.2.352
[33]	Papi A, De Carolis S, Bertoni S, et al. PPARγ and RXR ligands disrupt the inflammatory cross-talk in the hypoxic breast cancer stem cells niche[J]. J Cell Physiol, 2014, 229(11): 1595-1606. doi: 10.1002/jcp.24601
[34]	Hallenborg P, Petersen R K, Kouskoumvekaki I, et al. The elusive endogenous adipogenic PPARγ agonists: Lining up the suspects[J]. Prog Lipid Res, 2016, 61: 149-162. doi: 10.1016/j.plipres.2015.11.002
[35]	Dalla Nora E, Gray S L, Vidal-Puig A J. Mouse models of PPAR-γ deficiency: dissecting PPAR-γ′s role in metabolic homoeostasis[J]. Biochem Soc Trans, 2005, 33(5): 1053. doi: 10.1042/BST0331053
[36]	Chistiakov D A. The peroxisomal proliferator-activated receptor gamma isoform 2 (PPARgamma2) is an established susceptibility marker for type 2 diabetes (T2D)[J]. Autoimmunity, 2008, 41(5): 338-339. doi: 10.1080/08916930802011183
[37]	Wang S B, Dougherty E J, Danner R L. PPARγ signaling and emerging opportunities for improved therapeutics[J]. Pharmacol Res, 2016, 111: 76-85. doi: 10.1016/j.phrs.2016.02.028

[1]	ZHOU Xiaohua, ZOU Qi, JIN Wenjie, DAI Rongxiong, ZHANG Qian, ZHOU Wei, TANG Lin, FENG Jianping. Effects of different postures in prone position on postural complications in patients undergoing thoracolumbar surgery[J]. Journal of Clinical Medicine in Practice, 2023, 27(6): 51-54, 63. DOI: 10.7619/jcmp.20223594
[2]	ZHAI Minghua. Influence of perioperative predictive nursing on complications of patients undergoing gynecological pelvic surgery[J]. Journal of Clinical Medicine in Practice, 2020, 24(9): 124-126. DOI: 10.7619/jcmp.202009036
[3]	CONG Yanhua. Preventive nursing of bladder perfusion-induced complications after bladder cancer operation[J]. Journal of Clinical Medicine in Practice, 2017, (20): 66-68. DOI: 10.7619/jcmp.201720021
[4]	MOU Hongxia. Effect of comprehensive nursing on postoperative complications of patients with gynecologic laparoscopic surgery[J]. Journal of Clinical Medicine in Practice, 2017, (4): 132-134. DOI: 10.7619/jcmp.201704040
[5]	XIE Mei. Complications of biliary pancreatitis after surgery and its nursing countermeasures[J]. Journal of Clinical Medicine in Practice, 2017, (2): 73-75,79. DOI: 10.7619/jcmp.201702023
[6]	CHEN Hebo, GOU Juxiang. Application of quality care model in perioperative nursing in thyroid surgery patients[J]. Journal of Clinical Medicine in Practice, 2015, (20): 60-62,69. DOI: 10.7619/jcmp.201520019
[7]	WANG Caili, WANG Chunfei, LU Zongjun. Effect of comprehensive nursing on postoperative complications and recovery in patients with craniocerebral operation[J]. Journal of Clinical Medicine in Practice, 2015, (16): 57-59. DOI: 10.7619/jcmp.201516018
[8]	LI Guoying. Observation of postoperative complications of simple goiter patients and its nursing measures[J]. Journal of Clinical Medicine in Practice, 2015, (12): 64-66,77. DOI: 10.7619/jcmp.201512021
[9]	ZHUANG Zhaorong, YIN Daju. Nursing for gastric cancer patients with early postoperative complications[J]. Journal of Clinical Medicine in Practice, 2013, (12): 14-16,19. DOI: 10.7619/jcmp.201312006
[10]	CHEN Yunlan, QIU Meiling. Nursing for postoperative complications in patients with hysterectomy[J]. Journal of Clinical Medicine in Practice, 2013, (10): 95-97. DOI: 10.7619/jcmp.201310035

Cited By

Cited by

Periodical cited type(7)

1.	刘业琼，王蕾，曹励欧，徐炜新. 中段尿样本病原菌快速检测方法的建立与评估. 分子诊断与治疗杂志. 2025(03): 441-444 .
2.	袁佳春，许明佳，许艳丹，李伟，叶玉龙. 上海金山区宾馆淋浴水和公共浴室水中嗜肺军团菌MALDI-TOF MS快速检测及聚类分析. 中国卫生检验杂志. 2023(04): 426-428 .
3.	张小云，刘本，连建春，姜玉章，唐朝贵，王霞. 质谱鉴定联合直接快速药敏试验在细菌血流感染中的应用. 医学信息. 2023(03): 98-103 .
4.	蒲玉熙，次仁央金，嘎松卓嘎，赵颖，刘治娟. 高原地区两种微生物鉴定系统对临床常见病原菌鉴定的一致性分析. 中国实用医药. 2023(07): 97-99 .
5.	吴奇福. ALDI-TOF MS技术在微生物检验中的应用效果及效能ROC曲线. 中国医药指南. 2023(16): 121-124 .
6.	任燕飞，张敏，杨涛，李荣凯，梁新. 下呼吸道感染病原体检测方法及相关病原体研究. 中国现代医生. 2022(25): 114-117 .
7.	张鞠玲，康琳，鲍春梅，王欢，贾天野，陈素明，庞君丽，李伯安. MALDI-TOF MS技术直接鉴定无菌体液病原菌的效果评价. 国际检验医学杂志. 2022(24): 3016-3021 .

Other cited types(1)

Get Citation

PDF

XML

Article views (176) PDF downloads (3) Cited by(8)

Turn off MathJax

Article Contents

References

Relationship between peroxisome proliferator-activated receptor γ and gestational diabetes mellitus

References

Related Articles

Cited by

Periodical cited type(7)

Other cited types(1)

Catalog

Relationship between peroxisome proliferator-activated receptor γ and gestational diabetes mellitus

References

Related Articles

Cited by

Periodical cited type(7)

Other cited types(1)

Catalog

Export File

Citation

Format

Content